RaquibulHannanMDPhD

Radiation Oncology • Dallas, TX

Associate Professor of Radiation Oncology, UT Southwestern Medical Center

Join to view full profile

Dr. Hannan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hannan's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-645-8525

Fax+1 214-645-9233

Education & Training

Montefiore Medical Center/Albert Einstein College of MedicineResidency, Radiation Oncology, 2007 - 2011
SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 2006 - 2007
State University of New York, Downstate School of Graduate StudiesPh.D., 1999 - 2006
State University of New York Downstate Medical Center College of MedicineClass of 2006
New York UniversityB.A., Biochemistry, with Honors, 1996 - 1999

Certifications & Licensure

TX State Medical License 2011 - 2025
American Board of Radiology Radiation Oncology

Clinical Trials

Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer Start of enrollment: 2013 Jun 01
Active, not recruiting
Phase 2
Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC Start of enrollment: 2015 Jun 01
Active, not recruiting
Phase 1, Phase 2
SAbR For Oligometastatic Renal Cell Carcinoma Start of enrollment: 2018 Jul 19
Active, not recruiting
Phase 2
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer Start of enrollment: 2021 Sep 06
Terminated
Not Applicable
Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study Start of enrollment: 2023 Sep 07
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1 citations
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer.
Muhammad Ali, Young Suk Kwon, Kendrick Koo, Anna Bruynzeel, David Pryor
BJU International. 2025-01-01
3 citations
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report fr...
Vivian S Tan, Rohann J M Correa, Andrew Warner, Muhammad Ali, Alexander Muacevic
European Urology Oncology. 2024-12-01
Mapping cellular interactions from spatially resolved transcriptomics data.
James Zhu, Yunguan Wang, Woo Yong Chang, Alicia Malewska, Fabiana Napolitano
Nature Methods. 2024-10-01

Press Mentions

Clinical Trial Sets Stage for New Paradigm in Kidney Cancer TreatmentAugust 18th, 2022
Simmons Cancer Center Awarded Nearly $19 Million in CPRIT FundingMarch 7th, 2024